InvestSMART

Myfiziq Limited (ASX: MYQ) - Announcements

Current share price for MYQ : $1.915 0.115 (5.67%)+

ASX company news and announcements for Myfiziq Limited (MYQ) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Myfiziq Limited (MYQ) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Myfiziq Limited (MYQ), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Myfiziq Limited (MYQ)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- Change of Director's Interest Notice 16 Jul 2020 4:58PM $0.285 $1.915 risen by 571.93%
- Initial Director's Interest Notice 16 Jul 2020 4:55PM $0.285 $1.915 risen by 571.93%
- Proposed issue of Securities - MYQ 16 Jul 2020 4:50PM $0.285 $1.915 risen by 571.93%
- MyFiziq Appoints Dato Low Koon Poh to the MYQ Board 10 Jul 2020 8:24AM $0.285 $1.915 risen by 571.93%
- MyFiziq receives $1,038,000 in funding 9 Jul 2020 8:21AM $0.270 $1.915 risen by 609.26%
- CompleteHealth Integration Update 6 Jul 2020 9:08AM $0.275 $1.915 risen by 596.36%
- Appendix 2A 1 Jul 2020 4:59PM $0.280 $1.915 risen by 583.93%
- MyFiziq receives USD$450,000 and strengthens balance sheet 30 Jun 2020 8:18AM $0.280 $1.915 risen by 583.93%
- End of Financial Year Business Update 29 Jun 2020 8:21AM $0.280 $1.915 risen by 583.93%
- MyFiziq to expand technology into cancer care 22 Jun 2020 10:25AM $0.270 $1.915 risen by 609.26%
- MYQ reaches agreement in relation to convertible note debt 18 Jun 2020 8:27AM $0.240 $1.915 risen by 697.92%
- MyFiziq signs Memorandum of Understanding with NuraLogix 15 Jun 2020 8:19AM $0.275 $1.915 risen by 596.36%
- Evolt Application Launches on Apple App Store 9 Jun 2020 8:19AM $0.275 $1.915 risen by 596.36%
- ACAM Initial Payment Received for NASDAQ Listing Initiative 5 Jun 2020 8:27AM $0.210 $1.915 risen by 811.90%
- MyFiziq receives $600,000 R & D tax advance 2 Jun 2020 8:19AM $0.210 $1.915 risen by 811.90%
- USD$1,500,000 Funding for NASDAQ Dual Listing 1 Jun 2020 10:07AM $0.200 $1.915 risen by 857.50%
- Trading Halt 29 May 2020 1:46PM $0.200 $1.915 risen by 857.50%
- Pause in Trading 29 May 2020 1:09PM $0.195 $1.915 risen by 882.05%
- Appendix 4C Updated 18 May 2020 4:58PM $0.150 $1.915 risen by 1,176.67%
- MyFiziq signs definitive agreements with Bearn LLC 6 May 2020 8:21AM $0.175 $1.915 risen by 994.29%
- MyFiziq Granted Hong Kong Patent Protection 5 May 2020 10:11AM $0.170 $1.915 risen by 1,026.47%
- BCT signs definitive agreements with Active8me 4 May 2020 9:11AM $0.195 $1.915 risen by 882.05%
- Quarterly Update and Appendix 4C 30 Apr 2020 3:38PM $0.195 $1.915 risen by 882.05%
- MyFiziq signs definitive agreements with Active8me 28 Apr 2020 8:25AM $0.170 $1.915 risen by 1,026.47%
- Update to The CareVoice Announcement 20 Apr 2020 12:19PM $0.165 $1.915 risen by 1,060.61%

101 - 125 of 397 results

Page 5 of 16

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.